Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)

Condition:   Peanut Allergy
Interventions:   Biological: AR101 powder provided in capsules & sachets;   Biological: Placebo powder provided in capsules & sachets
Sponsor:   Aimmune Therapeutics, Inc.
Recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days